
|Articles|December 13, 2016
Effect of Adjuvant Chemo on Elderly Patients’ Quality of Life
Author(s)Bobby Lazzara, MD
In this Medical News Minute developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses recently published research that looks at quality of life outcome measures for elderly breast cancer patients who receive adjuvant chemotherapy.
Advertisement
In this Medical News Minute developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses recently published research that looks at quality of life outcome measures for elderly breast cancer patients who receive adjuvant chemotherapy.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
What Were The Most Impactful GU Oncology Data From ESMO 2025?
4
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
5



![“[This approval] will be a quite dramatic change in our philosophy and practice in multiple myeloma," according to Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3cab3ada4c023b68c118240a512e31d72a7f931b-1200x628.png?w=350&fit=crop&auto=format)















































































